Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04496518 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

StatusActive, Not Recruiting
PhaseNot specified
SponsorMedtronic
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of May 12, 2025 to Nov 6, 2024
    • Study completion date: Jan 31, 2027 to Jan 31, 2028
    v20
  2. Primary completion date: Jan 31, 2025 to May 12, 2025
    • Study sites revised (92)
    v19
  3. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 113 to 92
    v18
  4. Study sites: 114 to 113v17
  5. Site details revised at 1 of 114 sitesv16
Show 14 earlier versionsHide 14 earlier versions
  1. Site details revised at 1 of 114 sitesv15
  2. Site details revised at 1 of 114 sitesv14
  3. Site details revised at 1 of 114 sitesv13
  4. Site details revised at 4 of 114 sitesv12
  5. Study sites revised (114)v11
  6. Study sites: 95 to 114v10
  7. Re-verified, no change to tracked fieldsv9
  8. Study sites: 94 to 95v8
  9. Study sites: 57 to 94v7
  10. Study sites: 52 to 57v6
  11. Study sites: 47 to 52v5
  12. Study sites: 44 to 47v4
  13. Study sites: 34 to 44v3
  14. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 33 to 34
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Medtronic
16 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Trial Details
NCT Number NCT04496518
Lead Sponsor Medtronic
Conditions
(from sponsor)		 Ventricular Tachycardia
Related terms Tachycardia, Ventricular
Enrollment 2,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov